Reportedly hnRNPK serves as an oncogene in colorectal cancer, nasopharyngeal carcinoma, prostate cancer, melanoma, oral squamous cell carcinoma, and gastric cancer, such that its overexpression is negatively correlated with tumorigenesis and prognosis.1, 2, 3. This evidence concerns the gene HNRNPK and nasopharyngeal carcinoma.